The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.f

Anaphylaxis-Anaphylactoid reaction (can be fatal)

Publications

Stiehm ER

Adverse effects of human immunoglobulin therapy.

Transfusion medicine reviews. 2013;27(3):171-8

Salama A, Temmesfeld B, Hippenstiel S, Kalus U, Suttorp N, Kiesewetter H

A new strategy for the prevention of IgA anaphylactic transfusion reactions.

Transfusion. 2004;44(4):509-11

Menat C, Gil H, Démoly P, Dessard-Choupay G, Jacquet M, Dupond JL, Woronoff-Lemsi MC

[Anaphylactoid reactions to normal immunoglobulins].

Therapie. 2002;57(3):313-5

Duhem C, Dicato MA, Ries F

Side-effects of intravenous immune globulins.

Clinical and experimental immunology. 1994;97 Suppl 1(Suppl 1):79-83

Yocum MW, Kelso JM

Common variable immunodeficiency: the disorder and treatment.

Mayo Clinic proceedings. 1991;66(1):83-96